8. Sole Source Memo Clear Labs Annual Reagents and Service SS 68500001M.pdf
PDF 202 KB Posted
- Attached to
- Clear Labs PM and reagents for FY26 Sole Source
- Solicitation number
- 25-482DPH-OFCDI-B-49031
- Issued by
- Illinois
About this file
This document is a sole source provider letter from Clear Labs to the Illinois Department of Public Health, dated April 9, 2025, confirming the company's exclusive status as the sole manufacturer and authorized supplier of the Clear Dx™ Platform in the United States. The letter details a comprehensive range of next-generation sequencing (NGS) products, including multiple Clear Dx System configurations (LR, SR, LR-SR), system upgrades, service plans, installation and training services, and various reagent and automation bundles for genomic surveillance, microbial identification, and SARS-CoV-2 testing.
The product line encompasses 23 distinct items with part numbers ranging from 860001 to 900024, covering system hardware, software upgrades, service plans (1, 3, and 5-year options), installation and training services, and specialized reagent kits for different testing scenarios. The Clear Dx™ Platform is positioned as a fully automated, intelligent library preparation and NGS platform that enables public health officials, epidemiologists, and healthcare providers to make rapid, real-time genomic surveillance decisions with minimal labor requirements. The letter emphasizes Clear Labs' commitment to providing high-quality, innovative next-generation sequencing products for turnkey diagnostics.
View the file
Other files
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
April 9, 2025
Illinois Department of Public Health Attn: Dr. Joshua Geltz 825 N. Rutledge Street Springfield, IL 62702 RE: Sole Source Provider of the Clear Dx™ Platform
Thank you for choosing Clear Labs. Clear DxTM offers the only fully automated, intelligent library prep and NGS platform. The Clear DxTM Platform provides rapid, real-time genomic surveillance, enabling public health officials, epidemiologists and healthcare providers to make actionable and timely decisions with a fraction of the labor required.
We are pleased to confirm that Clear Labs is the only manufacturer and authorized supplier in the United States for the following products:
Part # Product Description 860001 Clear Dx System LR 860004 Clear Dx System SR 860005 Clear Dx System LR-SR 860006 Clear Dx Upgrade 860014 Clear Dx Upgrade - Microbial ID tNGS 850071 Clear Dx System Service Plan - 1 year 850072 Clear Dx System Service Plan - 3 year 850073 Clear Dx System Service Plan - 5 year 850067 Clear Dx System Installation & Training SR 850087 Clear Dx System Installation & Training LR-SR 850067 Clear Dx Upgrade Installation & Training 900025 Clear Labs IQ/OQ/PQ Services - Microbial ID tNGS 900021 Clear Labs IQ/OQ/PQ Services - LR-SR 900022 Clear Labs IQ/OQ/PQ Services - SR 900005 Clear Dx WGS SARS-CoV-2 Reagent v3.0 & Automation Bundle – 32 tests per run 900015 Clear Dx Microbial Surveillance WGS Reagent v2.0 & Automation Bundle 900020 Clear Dx FlexPro Wastewater (SARS-CoV-2) WGS Reagent & Automation Bundle 900023 Clear Dx Microbial ID tNGS (8 Tests) Reagent & Automation Bundle 900024 Clear Dx Microbial ID tNGS (16 Tests) Reagent & Automation Bundle
We are committed to providing you with high-quality, innovative next-generation sequencing products for turnkey diagnostics.
Best Regards, Edward Fan
Edward Fan Chief Financial Officer Clear Labs, Inc.
1559 Industrial Road • San Carlos • CA • 94070 • USA Tel: (650) 257-3304 edward.fan@clearlabs.com
File details come from the government source that posted it. Updated .